GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
21.94
-0.29 (-1.30%)
Jun 6, 2025, 2:45 PM CST
SHA:600771 Revenue
GuangYuYuan Chinese Herbal Medicine had revenue of 417.14M CNY in the quarter ending March 31, 2025, with 21.48% growth. This brings the company's revenue in the last twelve months to 1.30B, up 4.37% year-over-year. In the year 2024, GuangYuYuan Chinese Herbal Medicine had annual revenue of 1.22B, down -4.87%.
Revenue (ttm)
1.30B
Revenue Growth
+4.37%
P/S Ratio
8.27
Revenue / Employee
746.51K
Employees
1,735
Market Cap
10.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.22B | -62.59M | -4.87% |
Dec 31, 2023 | 1.28B | 153.30M | 13.56% |
Dec 31, 2022 | 1.13B | 276.50M | 32.37% |
Dec 31, 2021 | 854.22M | -255.21M | -23.00% |
Dec 31, 2020 | 1.11B | -107.67M | -8.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |